These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28528010)

  • 1. Long-term Safety and Efficacy of a Sustained-Release Bimatoprost Ocular Ring.
    Brandt JD; DuBiner HB; Benza R; Sall KN; Walker GA; Semba CP;
    Ophthalmology; 2017 Oct; 124(10):1565-1566. PubMed ID: 28528010
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of Topical Bimatoprost 0.01% and Timolol 0.5% on Circadian IOP, Blood Pressure and Perfusion Pressure in Patients with Glaucoma or Ocular Hypertension: A Randomized, Double Masked, Placebo-Controlled Clinical Trial.
    Oddone F; Rossetti L; Tanga L; Berardo F; Ferrazza M; Michelessi M; Roberti G; Manni G; Centofanti M
    PLoS One; 2015; 10(10):e0140601. PubMed ID: 26484767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Durysta - a bimatoprost implant for glaucoma.
    Med Lett Drugs Ther; 2020 Jul; 62(1603):116-117. PubMed ID: 32728012
    [No Abstract]   [Full Text] [Related]  

  • 4. Twelve-month, randomized, controlled trial of bimatoprost 0.01%, 0.0125%, and 0.03% in patients with glaucoma or ocular hypertension.
    Katz LJ; Cohen JS; Batoosingh AL; Felix C; Shu V; Schiffman RM
    Am J Ophthalmol; 2010 Apr; 149(4):661-671.e1. PubMed ID: 20346780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results From a Phase I/II Clinical Trial.
    Lewis RA; Christie WC; Day DG; Craven ER; Walters T; Bejanian M; Lee SS; Goodkin ML; Zhang J; Whitcup SM; Robinson MR;
    Am J Ophthalmol; 2017 Mar; 175():137-147. PubMed ID: 28012819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of ocular hypotensive action of bimatoprost (Lumigan) in patients with ocular hypertension or glaucoma.
    Christiansen GA; Nau CB; McLaren JW; Johnson DH
    Ophthalmology; 2004 Sep; 111(9):1658-62. PubMed ID: 15350319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained drug delivery for glaucoma: current data and future trends.
    Aref AA
    Curr Opin Ophthalmol; 2017 Mar; 28(2):169-174. PubMed ID: 27764023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety and efficacy of bimatoprost/timolol fixed combination: a 1-year double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertension.
    Lewis RA; Gross RL; Sall KN; Schiffman RM; Liu CC; Batoosingh AL;
    J Glaucoma; 2010 Aug; 19(6):424-6. PubMed ID: 19855289
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4.
    Williams RD; Cohen JS; Gross RL; Liu CC; Safyan E; Batoosingh AL;
    Br J Ophthalmol; 2008 Oct; 92(10):1387-92. PubMed ID: 18621791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular hypotensive efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.
    Cantor LB; WuDunn D; Cortes A; Hoop J; Knotts S
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S12-8. PubMed ID: 15016557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability and efficacy of bimatoprost 0.01 % in patients with open-angle glaucoma or ocular hypertension evaluated in the Taiwanese clinical setting: the Asia Pacific Patterns from Early Access of Lumigan 0.01 % (APPEAL Taiwan) study.
    Chen YY; Wang TH; Liu C; Wu KY; Chiu SL; Simonyi S; Lu DW
    BMC Ophthalmol; 2016 Sep; 16(1):162. PubMed ID: 27633513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension.
    Cohen JS; Gross RL; Cheetham JK; VanDenburgh AM; Bernstein P; Whitcup SM
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S45-52. PubMed ID: 15016561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bimatoprost and bimatoprost/timolol fixed combination in patients with open-angle glaucoma and ocular hypertension.
    Katsanos A; Dastiridou AI; Fanariotis M; Kotoula M; Tsironi EE
    J Ocul Pharmacol Ther; 2011 Feb; 27(1):67-71. PubMed ID: 21214361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of bimatoprost for the treatment of open-angle glaucoma and ocular hypertension: a three-month, open-label study in community-based practices in Thailand.
    Wanichwecha-Rungruang B; Iemsomboon W
    J Med Assoc Thai; 2005 Sep; 88(9):1228-35. PubMed ID: 16536109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial.
    Rossetti L; Sacchi M; Karabatsas CH; Topouzis F; Vetrugno M; Centofanti M; Boehm A; Vorwerk C; Goldblum D; Fogagnolo P
    BMC Ophthalmol; 2015 Jan; 15():7. PubMed ID: 25613811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicentre evaluation of the effect of patient education on acceptance of hyperaemia associated with bimatoprost therapy for glaucoma or ocular hypertension.
    Trattler W; Noecker RJ; Earl ML
    Adv Ther; 2008 Mar; 25(3):179-89. PubMed ID: 18351298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six-Month Intraocular Pressure Reduction with a Topical Bimatoprost Ocular Insert: Results of a Phase II Randomized Controlled Study.
    Brandt JD; Sall K; DuBiner H; Benza R; Alster Y; Walker G; Semba CP;
    Ophthalmology; 2016 Aug; 123(8):1685-1694. PubMed ID: 27157843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin-associated periorbitopathy.
    Shrirao N; Khurana M; Mukherjee B
    Indian J Ophthalmol; 2016 Jun; 64(6):459. PubMed ID: 27488155
    [No Abstract]   [Full Text] [Related]  

  • 19. Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular hypertension.
    Whitson JT; Trattler WB; Matossian C; Williams J; Hollander DA
    J Ocul Pharmacol Ther; 2010 Jun; 26(3):287-92. PubMed ID: 20578283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost.
    Gandolfi SA; Cimino L
    Ophthalmology; 2003 Mar; 110(3):609-14. PubMed ID: 12623831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.